Overview
Advisory Business
BelHealth Investment Partners, LLC ("BelHealth or the "Investment Adviser"), a Delaware
limited liability company, commenced operations in 2011. Founded by Harold Blue, BelHealth
is owned by Harold Blue, Inder Tallur, Joseph P. Wynne, and KP Family BelHealth
Investments, LLC. Mr. Blue is the Manager of BelHealth. The affiliated General Partner for
each private partnership has entered into an advisory agreement with the Investment Adviser
to manage BelHealth Investment Fund, L.P. ("Fund I") and BelHealth Investment Fund II, L.P.
("Fund II") (each, a "Fund", and together, the "Funds"). The Investment Adviser pursues a
private equity strategy on behalf of the Funds. Interests in the Funds are offered to qualified
investors. Investors and potential investors in the Funds should consult the Funds' offering
documents, including the applicable Limited Partnership Agreements and Private Placement
Memorandum, for a comprehensive discussion of the Funds and the risk factors associated with
each Fund. In providing services to the Funds, BelHealth formulates each Fund’s investment
objectives, directs and manages the investment of each Fund’s assets, and provides reports to
investors. Investment advice is provided directly to the Funds and not individually to the
investors of the Funds. BelHealth manages the assets of the Funds in accordance with the terms
of
each Fund’s partnership agreement and other applicable governing documents.
Our registration on Form ADV also covers BelHealth Investment Management, LLC,
a limited liability company organized under the laws of the State of Delaware and BelHealth
Investment Partners GP II, LLC, a limited liability company organized under the laws of the
State of Delaware (collectively with BelHealth Investment Management, LLC, the "Fund
General Partners"). The Fund General Partners are affiliates of the Investment Adviser and
serve as the general partner of the Funds.
The Funds invest in select healthcare companies by acquiring businesses that the
Investment Adviser considers undervalued or under-managed and where the Investment
Adviser believes it can leverage its investment and operational experience to achieve superior
investment returns. The Investment Adviser may also cause the Funds to invest in other
situations that the Investment Adviser believes to be in the best interest of the applicable Fund.
As of December 31, 2022, the most recent figures available, the Investment Adviser
had $337,109,097 in regulatory assets under management, all of which it manages on a
discretionary basis.
As used herein, the term "client" generally refers to each Fund.
For additional discussion of the Funds, and their investment objectives and risks, please see
response to Item 8.